These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
630 related items for PubMed ID: 9812525
21. [Immune status of a school-population sample 5 years after antirubella vaccination]. Quaglio P, Dattoli A, Mantovani G. G Batteriol Virol Immunol; 1982; 75(7-12):233-8. PubMed ID: 7188256 [Abstract] [Full Text] [Related]
22. Susceptibility to rubella and borderline immunity. Fogel A, Barnea B, Gerichter CB. Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349 [Abstract] [Full Text] [Related]
23. The immunoglobulin response to reimmunization with rubella vaccine. Scott RM, Schydlower M, Lampe RM, Schwab JA, Muelenaer AA. J Pediatr; 1981 Oct; 99(4):531-4. PubMed ID: 7277092 [Abstract] [Full Text] [Related]
24. [Antibody response to live rubella vaccination and its clinical meanings]. Hoshiba T, Yabuki Y, Asamoto A, Kimura N, Tanaka J. Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2029-35. PubMed ID: 3429985 [Abstract] [Full Text] [Related]
25. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine. Riddell M, Senn N, Clements CJ, Hobday L, Cowie B, Kurubi J, Kevin A, Siba P, Reeder JC, Morgan C. Vaccine; 2012 Dec 14; 30(52):7506-12. PubMed ID: 23103194 [Abstract] [Full Text] [Related]
26. [Effect of vaccination on immune status in pregnancy]. Topolovec J. Lijec Vjesn; 1999 Mar 14; 121(3):73-8. PubMed ID: 10437345 [Abstract] [Full Text] [Related]
27. [Rubella vaccination using Cendehill's live virus vaccine]. Vivell O, Merschmann E, Lips G, Reiss G. Arch Kinderheilkd; 1969 Sep 14; 179(3):259-66. PubMed ID: 5350790 [No Abstract] [Full Text] [Related]
28. [Immune status against measles and rubella among 4 Chilean groups of different ages]. Valenzuela MT, Vega J, Leal I, Vicente M, Young V, Vera L, Fasce R, Ramírez E. Rev Med Chil; 1999 Mar 14; 127(3):359-65. PubMed ID: 10436723 [Abstract] [Full Text] [Related]
29. Rubella epidemic in an institution: protective value of live rubella vaccine and serological behavior of vaccinated, revaccinated and naturally immune groups. Baba K, Yabuuchi H, Okuni H, Harima R, Minekawa Y, Taniuchi M, Otsuka T, Takahashi M, Okuno Y. Biken J; 1978 Mar 14; 21(1):25-31. PubMed ID: 666723 [Abstract] [Full Text] [Related]
30. Rubella prevention in family practice with RA27/3 vaccine. Hansen NH. J Fam Pract; 1980 Oct 14; 11(4):537-42. PubMed ID: 7420029 [Abstract] [Full Text] [Related]
31. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001. Malakmadze N, Zimmerman LA, Uzicanin A, Shteinke L, Caceres VM, Kasymbekova K, Sozina I, Glasser JW, Joldubaeva M, Aidyralieva C, Icenogle JP, Strebel PM, Reef SE. Clin Infect Dis; 2004 Jun 15; 38(12):1780-3. PubMed ID: 15227627 [Abstract] [Full Text] [Related]
32. [Test of anti-rubella vaccination with live and attenuated virus (Cendehill strain)]. Leogrande G, Barnaba L, Iandolo E, Iatta E. Minerva Med; 1970 Apr 14; 61(30 Suppl):1595-8. PubMed ID: 4378365 [No Abstract] [Full Text] [Related]
33. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE. J Infect Dis; 2004 May 01; 189 Suppl 1():S116-22. PubMed ID: 15106100 [Abstract] [Full Text] [Related]
34. Studies on live rubella vaccine. IV. Comparative field trials with attenuated vaccines at different passage levels in Japanese quail embryo fibroblast cells. Minekawa Y, Suzuki N, Osame J, Ueda S, Yamanishi K. Biken J; 1973 Dec 01; 16(4):155-60. PubMed ID: 4799207 [No Abstract] [Full Text] [Related]
35. Rubella immunity measured by hemagglutination inhibition and enzyme-linked immunosorbent assay. Hornstein L, Swartz TA, Heimann M. Isr J Med Sci; 1985 Aug 01; 21(8):666-9. PubMed ID: 4044233 [Abstract] [Full Text] [Related]
36. The 2001 serological survey in the Czech Republic--rubella. Mrázová M, Smelhausová M, Sestáková Z, Svandová E, Benes C. Cent Eur J Public Health; 2003 Dec 01; 11 Suppl():S42-9. PubMed ID: 15080259 [Abstract] [Full Text] [Related]
37. [Level of antibodies against rubella in the normal population of Nanning city and a survey of the immunizing efficacy of rubella live-vaccines]. Chen J. Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Feb 01; 6(1):12-4. PubMed ID: 3995568 [No Abstract] [Full Text] [Related]
38. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan. Tseng HF, Chang CK, Tan HF, Yang SE, Chang HW. Vaccine; 2006 Jul 17; 24(29-30):5772-7. PubMed ID: 16759764 [Abstract] [Full Text] [Related]
39. Waning antibodies in measles and rubella vaccinees--a longitudinal study. Kremer JR, Schneider F, Muller CP. Vaccine; 2006 Mar 24; 24(14):2594-601. PubMed ID: 16427163 [Abstract] [Full Text] [Related]
40. Guide to the management of rubella problems. Middleton PJ, Larke RP, Lessard P, Doran TA. Can Med Assoc J; 1977 Mar 05; 116(5):484-8. PubMed ID: 837313 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]